Locations
San Francisco, CA, USA · South San Francisco, CA, USA
industry
Biotechnology
Size
51-200 employees
Stage
Other
founded in
2015
Verge Genomics is a next-generation biopharmaceutical start-up using systems biology to accelerate the development of life-saving treatments for neurodegenerative diseases. Our platform uses patient genomes, gene expression, and epigenomics to identify new therapeutic gene targets, predict effective drugs, and stratify patient subpopulations for increased clinical success. Verge's approach offers a breakthrough opportunity to identify drugs that dramatically improve patient outcomes and fundamentally lower the cost curve of pharmaceutical development. We are looking for extraordinary individuals to join our motivated team in taking on our generation’s biggest healthcare challenges: ALS, Parkinson’s disease, and Alzheimer’s disease. Our employees are our most important asset; we are a team of founders, excited to learn, roll up our sleeves, and make a real impact. The start-up nature of Verge Genomics provides multiple growth opportunities into other areas of the company.
Something looks off?
